Early Recognition and Initiation of Temozolomide Chemotherapy for Refractory, Invasive Pituitary Macroprolactinoma with Long-Term Sustained Remission
Keywords: آدنوم هیپوفیزی; Atypical prolactinoma; Chemotherapy; Dopamine agonist; Invasive adenoma; Pituitary adenoma; Refractory prolactinoma; Temozolomide; DA; Dopamine agonist; MRI; Magnetic resonance imaging; SRS; Stereotactic radiosurgery; TMZ; Temozolomide;